Trial of MSC1936369B in Subjects With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

182

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2016

Conditions

Solid TumorsCancer

Interventions

DRUG

MSC1936369B

DRUG

MSC1936369B

DRUG

MSC1936369B

DRUG

MSC1936369B

Trial Locations (9)

Hôpital Beaujon, Paris

Westmead Hospital, Westmead

Ghent University Hospital, Ghent

Institute Bergonié, Bordeaux

Hopital Saint Louis, Paris

Centre Eugène Marquis, Rennes

Netherlands Cancer Institute - Antonie van Leeuwenhoek Hospital, Amsterdam

Jules Bordet Institute, Brussels

Institute Claudius Regaud, Toulouse

All Listed Sponsors

collaborator

Merck Serono S.A., Geneva

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT00982865 - Trial of MSC1936369B in Subjects With Solid Tumors | Biotech Hunter | Biotech Hunter